Showing results (271-280 of 2,640) with videos related to
Sort By:
Pageof 264
Leukemia|July 1, 1987
Mitoxantrone and ara-C in previously treated patients with acute myelogenous leukemiaP A Paciucci, J P Dutcher, J Cuttner, et al.Cancer|March 15, 1991
13-cis-retinoic acid in the treatment of elderly patients with acute myeloid leukemia. A phase II pilot study of the Eastern Cooperative Oncology GroupZ B Kramer, L Boros, P H Wiernik, et al.American Journal of Clinical Oncology|October 1, 1990
Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancerJ A Sparano, E L Schwartz, K M Salva, et al.Leukemia|July 1, 1994
The immunophenotype of acute promyelocytic leukemia (APL): an ECOG studyE Paietta, J Andersen, R Gallagher, et al.European Journal of Haematology|March 25, 1999
Circulating haemopoietic progenitor cells in primary and secondary myelofibrosis: relation to collagen and reticulin fibrosisM D Colović, P H Wiernik, G M Janković, et al.American Journal of Nephrology|January 1, 1991
Interstitial nephritis in a patient receiving adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cellsD A Feinfeld, V D'Agati, J P Dutcher, et al.Leukemia|October 1, 1995
A phase II study of menogaril (7R-O-methylnogarol) in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology GroupJ P Dutcher, T Leong, A Z Makary, et al.Investigational New Drugs|September 18, 1998
Phase I study of paclitaxel (taxol) and granulocyte colony stimulating factor (G-CSF) in patients with unresectable malignancyA I Einzig, P H Wiernik, S Wadler, et al.Cancer Research|May 1, 1987
Phase I clinical and pharmacokinetic study of taxolP H Wiernik, E L Schwartz, J J Strauman, et al.Leukemia|June 1, 1994
Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analysesE Paietta, J Andersen, J Racevskis, et al.Pageof 264